+28%

est. 2Y upside i

HealthcareAI & MLSeries A

Rank

#1430

Sector

Biotech, AI, Cell Therapy

Est. Liquidity

~5Y

Data Quality

Data: Low

Joining Somite offers high risk/high reward potential.

Last updated: July 19, 2026

Bull (20%)+180%

If the DeltaStem platform achieves clinical validation and a major pharma partnership (like Novo Nordisk) expands, valuation could increase 3-5x. With strong AI moat and no competition, bull case implies exit valuation of ~$400M+, net of 20% dilution.

Base (55%)+30%

Steady progress in pipeline and partnerships leads to modest valuation appreciation. Base case valuation ~$130M after 2 years, driven by continued investor interest in AI cell therapy.

Bear (25%)-100%

If clinical setbacks or funding issues arise, the company may struggle to raise capital. With $60M preference overhang, common stock could be wiped out if exit valuation <$60M.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

6000%

Total funding of $60M implies preference overhang of 60% of assumed entry valuation ($100M), meaning common stock only participates after ~$60M exit.

Dilution Risk

high

With $60M raised and high burn rate, a down round or flat round within 24 months is likely, diluting current equity by an estimated 20%.

Secondary Liquidity

none

No secondary market indicated; shares are illiquid until a liquidity event (IPO or acquisition).

Other — 2 roles

View all 2 open roles at Somite →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Somite's data — designed to show you've done your homework.

  • 1

    “How does DeltaStem's data generation efficiency translate into faster clinical timelines versus competitors?”

  • 2

    “What are the key milestones for the Novo Nordisk partnership and how do they impact revenue?”

  • 3

    “Given the lack of revenue, what is your outlook on the next funding round and potential dilution?”

Community

Valuation Sentiment

Our model estimates +28% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.